Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Edan

Showing results (21-30 of 149) with videos related to

Pageof 15
Sort By:
Brain : a Journal of Neurology|March 19, 2019
Multiple sclerosis: effect of beta interferon treatment on survivalElaine Kingwell, Emmanuelle Leray, Feng Zhu, et al.
Journal of Neurology|January 9, 2010
3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort studyLaurent Flet, Elisabeth Polard, Olivia Guillard, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|October 6, 2005
Effects of pregnancy and child birth on urinary symptoms and urodynamics in women with multiple sclerosisAurélie Durufle, Sabine Petrilli, Benoit Nicolas, et al.
JMIR Medical Informatics|January 29, 2025
Digital Representation of Patients as Medical Digital Twins: Data-Centric ViewpointStanislas Demuth, Jérôme De Sèze, Gilles Edan, et al.
Presse Medicale (Paris, France : 1983)|April 16, 2013
[Neuropsychiatric manifestations in multiple sclerosis (MS): Might psychotic symptoms signal the onset of the disease?]Nathalie Guernion, Emeline Le Cadet, Anne Tirel, et al.
Brain : a Journal of Neurology|April 29, 2010
Evidence for a two-stage disability progression in multiple sclerosisEmmanuelle Leray, Jacqueline Yaouanq, Emmanuelle Le Page, et al.
Presse Medicale (Paris, France : 1983)|June 14, 2015
A retrospective study on the efficacy and safety of intraveinous immunoglobulin (Tegeline®) in patients with chronic inflammatory demyelinating polyneuropathyFlorence Robert, Gilles Edan, Guillaume Nicolas, et al.
BMC Neurology|December 1, 2014
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosisPhilippe Manceau, Clotilde Latarche, Sophie Pittion, et al.
Case Reports in Medicine|August 28, 2009
Mitoxantrone therapy for acute posterior multifocal placoid pigment epitheliopathy with cerebral vasculitisHélène Massé, Jean-Laurent Guyomard, Dominique Baudet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2007
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patientsEmmanuelle Le Page, Emmanuelle Leray, Grégory Taurin, et al.
Pageof 15

Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Brain : a Journal of Neurology|March 19, 2019
Multiple sclerosis: effect of beta interferon treatment on survivalElaine Kingwell, Emmanuelle Leray, Feng Zhu, et al.
Journal of Neurology|January 9, 2010
3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort studyLaurent Flet, Elisabeth Polard, Olivia Guillard, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|October 6, 2005
Effects of pregnancy and child birth on urinary symptoms and urodynamics in women with multiple sclerosisAurélie Durufle, Sabine Petrilli, Benoit Nicolas, et al.
JMIR Medical Informatics|January 29, 2025
Digital Representation of Patients as Medical Digital Twins: Data-Centric ViewpointStanislas Demuth, Jérôme De Sèze, Gilles Edan, et al.
Presse Medicale (Paris, France : 1983)|April 16, 2013
[Neuropsychiatric manifestations in multiple sclerosis (MS): Might psychotic symptoms signal the onset of the disease?]Nathalie Guernion, Emeline Le Cadet, Anne Tirel, et al.
Brain : a Journal of Neurology|April 29, 2010
Evidence for a two-stage disability progression in multiple sclerosisEmmanuelle Leray, Jacqueline Yaouanq, Emmanuelle Le Page, et al.
Presse Medicale (Paris, France : 1983)|June 14, 2015
A retrospective study on the efficacy and safety of intraveinous immunoglobulin (Tegeline®) in patients with chronic inflammatory demyelinating polyneuropathyFlorence Robert, Gilles Edan, Guillaume Nicolas, et al.
BMC Neurology|December 1, 2014
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosisPhilippe Manceau, Clotilde Latarche, Sophie Pittion, et al.
Case Reports in Medicine|August 28, 2009
Mitoxantrone therapy for acute posterior multifocal placoid pigment epitheliopathy with cerebral vasculitisHélène Massé, Jean-Laurent Guyomard, Dominique Baudet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2007
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patientsEmmanuelle Le Page, Emmanuelle Leray, Grégory Taurin, et al.
Pageof 15